News
23h
Zacks Investment Research on MSNGSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
GSK plc GSK reported second-quarter 2025 core earnings of $1.23 per American depositary share (ADS), which beat the Zacks ...
1d
Tuko News on MSNGSK reports improved outlook despite US drug tariffs
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...
GSK Stock Performance GSK stock opened at $38.66 on Friday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.58 and a current ratio of 0.87.
GSK is scheduled to report results for the first quarter on Wednesday. Here is what to know. SALES FORECAST: The British pharmaceutical giant is expected to report sales for the period of 7.42 ...
With the stock's last traded price at Rs 3,081, GlaxoSmithKline Pharmaceuticals has experienced a notable decline, positioning it among the top losers on the Nifty Midcap 150 index.
GSK GSK stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, regulatory and pipeline successes and an optimistic outlook for the long ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results